Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib
Rohit K Jain, Hongbin Chen Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Abstract: In the last decade, there have been major therapeutic advances in the management of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. Crizotinib was the...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017-10-01
|
| Serier: | Lung Cancer: Targets and Therapy |
| Fag: | |
| Online adgang: | https://www.dovepress.com/spotlight-on-brigatinib-and-its-potential-in-the-treatment-of-patients-peer-reviewed-article-LCTT |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|